Abstract:Objective To investigate the molecular mechanism of sterol regulatory element binding protein-1c (SREBP-1c) suppressing insulin receptor substrate-1(IRS-1) in skeletal muscle cells. Methods Luciferase plasmid for rat IRS-1 promoter, expression plasmid of SREBP-1c and pRL-TK renilla plasmid were cotransfected into L6 cells using Lipofectamine 2000 (Invitrogen). After transfection for 36 h, luciferase activity was measured using the dual-luciferase reporter assay system following the manufacturer' s instructions. L6 myotubes were infected with adenoviral vectors expressing SREBP-1c. Adenovirus expressing green fluorescent protein (GFP) was used as control. The cells were harvested for nucleus protein after infection for 48 h. Electrophoretic mobility shift assay (EMSA) was performed using a Light Shift Chemiluminescent EMSA Kit. Chromatin immunoprecipitation assay was performed by CHIP Kit. The interaction between the transcription factor SREBP-1c and the promoter region of IRS-1 was assessed by above experiments. Differences among the groups were determined using two-way ANOVA. Results The luciferase deletion studies suggested the region from-450 to-210 bp on the IRS-1 promoter was a potential target region for SREBP-1c. Sequence analysis showed that the target region of the rat IRS-1 promoter gene contained a potential binding site (GCCTCCCGAG), which was located between-302 and-292 bp. PCR site-directed mutagenesis (TGTTAAATTA) was generated and analyzed using a luciferase assay. The transcriptional activity of wild-type IRS-1 promoter was dramatically down-regulated by SREBP-1c, whereas SREBP-1c had no effect on the IRS-1 promoter bearing mutation of SREBP-1c binding site(7.03 ± 1.28 vs 19.09 ± 2.45,3.55 ± 1.68 vs 3.96 ± 1.09,F=114.437,0.251,all P>0.05). The EMSA results showed that the labeled wild-type probe successfully formed a complex with nuclear proteins. But the unlabelled mutant probe did not interfere the complex. The results from CHIP assay showed that SREBP-1c could bind directly to the IRS-1 promoter region. The quantity of SREBP-1c protein binding to the IRS-1 promoter was two times of control under PA conditions in L6 cells or five times of control when SREBP-1c was over-expressed (2.15 ± 0.03 vs 1.07 ± 0.24,5.48 ± 1.28 vs 0.86 ± 0.19,t=6.877,5.495,all P<0.05). Conclusion SREBP-1c could directly bind to the atypical SRE sequence in the promoter region of IRS-1, suppressing IRS-1 expression and the subsequent insulin signaling pathway.

Discovery of Novel Binders to Sterol Regulatory Element-Binding Protein-1 by High-Throughput Screening

A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation

Anhydroicaritin Improves Diet-Induced Obesity and Hyperlipidemia and Alleviates Insulin Resistance by Suppressing SREBPs Activation

Sterol regulatory element binding proteins and lipid metabolism

Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway

[Sterol Regulatory Element Binding Protein 1 and Its Target Gene Networks].

SREBP： a Novel Therapeutic Target

Sterol regulatory element binding protein and nonalcoholic fatty liver disease

Discovery of Core-Structurally Novel PTP1B Inhibitors with Specific Selectivity Containing Oxindole-Fused Spirotetrahydrofurochroman by One-Pot Reaction.

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies

Discovery of Novel S6K1 Inhibitors by an Ensemble-Based Virtual Screening Method and Molecular Dynamics Simulation

The Molecular Mechanism of Sterol Regulatory Element Binding Protein-1C Suppressing Insulinreceptor Substrate-1 in Skeletal Muscle

2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic Acid Ameliorates Metabolic Disorders in High-Fat Diet-Fed Mice

Recent Advances in Research on Natural Product Inhibitors of SREBPs

Sterol-responsive Element-binding Protein (SREBP) 2 Down-regulates ATP-binding Cassette Transporter A1 in Vascular Endothelial Cells: A NOVEL ROLE OF SREBP IN REGULATING CHOLESTEROL METABOLISM

Discovery of an Insulin-Induced Gene Binding Compound That Ameliorates Nonalcoholic Steatohepatitis by Inhibiting Sterol Regulatory Element-Binding Protein-Mediated Lipogenesis.

[Effects of Transcription Factor Sterol Regulatory Element Binding Protein-1C in Palmitate Acid-Induced L6 Cells Insulin Resistance and Its Mechanism].

Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives to Reduce SREBPs Expression for the Treatment of Hyperlipidemia.

Discovery of a INSIG binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting SREBP‐mediated lipogenesis

Targeting Allosteric Site of PCSK9 Enzyme for the Identification of Small Molecule Inhibitors: An In Silico Drug Repurposing Study

Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription